Zura Bio
ZURA
94 hedge funds and large institutions have $392M invested in Zura Bio in 2026 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 12 closing their positions.
167% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 12
67% more capital invested
Capital invested by funds: $235M → $392M (+$157M)
25% more funds holding
Funds holding: 75 → 94 (+19)
20% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 25
0.61% more ownership
Funds ownership: 69.01% → 69.62% (+0.61%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
100% less call options, than puts
Call options by funds: $1K | Put options by funds: $2.58M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$21.1M |
| 2 |
CC
Commodore Capital
New York
|
+$19.6M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$14.7M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$8.76M |
| 5 |
QF
QVT Financial
New York
|
+$7.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$3.84M |
| 2 |
Jane Street
New York
|
-$2.29M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.76M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.43M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.39M |
ZURA Hedge Fund Activity: Q1 2026 in Review
94 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q1 2026, worth a combined $392M — up 67% from $235M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new ZURA positions and 12 closed out — a net gain of 20 holders — while 30 added to existing stakes and 25 trimmed.
The largest buyer was Suvretta Capital Management, adding an estimated $21.1M. The largest seller was Morgan Stanley, cutting an estimated $3.84M.
- 94 institutional investors held Zura Bio (ZURA) as of Q1 2026, up from 75 in Q4 2025.
- Funds reported $392M of Zura Bio stock for Q1 2026, up 67% quarter-over-quarter.
- 32 funds opened new Zura Bio positions in Q1 2026 and 12 closed out, a net change of +20 holders.
- The largest Zura Bio buyer in Q1 2026 was Suvretta Capital Management, an estimated $21.1M added.
- The largest Zura Bio seller in Q1 2026 was Morgan Stanley, an estimated $3.84M sold.
Based on aggregated 13F filings for Q1 2026.